Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biological pathways to bladder carcinogenesis.

M L Gonzalgo1, M P Schoenberg, R Rodriguez

  • 1Department of Urology, The James Buchanan Brady Urological Institute, Baltimore, MD 21287, USA.

Seminars in Urologic Oncology
|December 2, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis.

Oncogene·2015
Same author

Clinical significance of denuded urothelium in bladder biopsy.

The Journal of urology·2001
Same author

Renal artery pseudoaneurysm occurring after partial nephrectomy.

Urology·2001
Same author

Correlation of cystoscopic impression with histologic diagnosis of biopsy specimens of the bladder.

Human pathology·2001
Same author

Successful conservative management of perforated ileal neobladder.

The Journal of urology·2001
Same author

Absence of karyotype abnormalities in patients with familial urothelial cell carcinoma.

Urology·2001
Same journal

The role of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors: current concepts and controversies.

Seminars in urologic oncology·2002
Same journal

Poor prognosis germ-cell tumors: An unresolved challenge.

Seminars in urologic oncology·2002
Same journal

Chemotherapy for good-risk germ-cell tumors.

Seminars in urologic oncology·2002
Same journal

Adjuvant chemotherapy for stage II nonseminomatous germ-cell tumors.

Seminars in urologic oncology·2002
Same journal

Contralateral testicular biopsy procedure in patients with unilateral testis cancer: is it indicated?

Seminars in urologic oncology·2002
Same journal

Controversies in the management of testicular seminoma.

Seminars in urologic oncology·2002
See all related articles

Understanding human bladder carcinogenesis is key to developing new treatments for bladder cancer. Research explores molecular events and biological pathways in normal urothelium progression to neoplastic states.

Area of Science:

  • Oncology
  • Urology
  • Molecular Biology

Background:

  • Bladder cancer development involves the transformation of normal urothelium into neoplastic states.
  • Current clinical management of bladder cancer benefits from scientific discoveries.
  • Understanding carcinogenesis mechanisms is crucial for novel treatment strategies.

Purpose of the Study:

  • To discuss the biological pathways of human bladder carcinogenesis.
  • To outline recent advances in understanding normal urothelium progression to superficial or invasive bladder cancer.

Main Methods:

  • Review of in vitro culture systems.
  • Analysis of in vivo animal models.
  • Examination of key molecular events in bladder cancer development.

Related Experiment Videos

Main Results:

  • Characterization of normal urothelium transformation into neoplastic states.
  • Identification of key molecular events in bladder cancer.
  • Elucidation of biological pathways in disease progression.

Conclusions:

  • Advances in understanding bladder cancer mechanisms are essential for developing new therapies.
  • In vitro and in vivo models are critical for defining molecular events in carcinogenesis.
  • Further research into biological pathways will inform future treatment strategies for bladder cancer.